Inventory Summary of ImmunoPrecise Antibodies Ltd.

ImmunoPrecise Antibodies Ltd.'s latest annual inventory in 2023 was 2.13 Million CAD , up 3.83% from previous year.
ImmunoPrecise Antibodies Ltd.'s latest quarterly inventory in 2024 Q1 was 1.86 Million CAD , down -24.81% from previous quarter.
ImmunoPrecise Antibodies Ltd. reported annual inventory of 2.06 Million CAD in 2022, up 27.55% from previous year.
ImmunoPrecise Antibodies Ltd. reported annual inventory of 1.61 Million CAD in 2021, up 34.14% from previous year.
ImmunoPrecise Antibodies Ltd. reported quarterly inventory of 2.13 Million CAD for 2023 FY, up 3.83% from previous quarter.
ImmunoPrecise Antibodies Ltd. reported quarterly inventory of 2.13 Million CAD for 2023 Q4, down -15.52% from previous quarter.

Annual Inventory Chart of ImmunoPrecise Antibodies Ltd. (2023 - 1996)

Historical Annual Inventory of ImmunoPrecise Antibodies Ltd. (2023 - 1996)

Year	Inventory	Inventory Growth
2023	2.13 Million CAD	3.83%
2022	2.06 Million CAD	27.55%
2021	1.61 Million CAD	34.14%
2020	1.2 Million CAD	47.07%
2019	818.64 Thousand CAD	-61.4%
2018	2.12 Million CAD	413.9%
2017	412.69 Thousand CAD	605.47%
2016	58.49 Thousand CAD	1999.75%
2015	2786.00 CAD	278500.0%
2014	1.00 CAD	0.0%
2013	- CAD	0.0%
2012	- CAD	0.0%
2011	- CAD	0.0%
2010	- CAD	0.0%
2009	- CAD	0.0%
2008	- CAD	0.0%
2007	- CAD	0.0%
2006	- CAD	-100.0%
2005	13.55 Thousand CAD	0.0%
2004	- CAD	0.0%
2003	- CAD	0.0%
2002	- CAD	0.0%
2001	- CAD	0.0%
2000	- CAD	0.0%
1999	- CAD	0.0%
1998	- CAD	0.0%
1997	- CAD	0.0%
1996	- CAD	0.0%

Year	Inventory	Inventory Growth
2024 Q1	1.86 Million CAD	-24.81%
2023 FY	2.13 Million CAD	3.83%
2023 Q4	2.13 Million CAD	-15.52%
2023 Q1	1.54 Million CAD	-24.81%
2023 Q2	2.45 Million CAD	58.3%
2023 Q3	2.53 Million CAD	3.26%
2022 Q2	1.58 Million CAD	2.32%
2022 Q4	2.06 Million CAD	13.94%
2022 Q1	1.54 Million CAD	-4.09%
2022 FY	2.06 Million CAD	27.55%
2022 Q3	1.8 Million CAD	14.07%
2021 Q2	1.27 Million CAD	-1.39%
2021 Q3	1.53 Million CAD	20.13%
2021 Q1	1.29 Million CAD	7.56%
2021 Q4	1.61 Million CAD	5.28%
2021 FY	1.61 Million CAD	34.14%
2020 FY	1.2 Million CAD	47.07%
2020 Q1	1.01 Million CAD	24.31%
2020 Q3	1.23 Million CAD	9.5%
2020 Q4	1.2 Million CAD	-2.22%
2020 Q2	1.12 Million CAD	10.5%
2019 Q4	818.64 Thousand CAD	-64.01%
2019 FY	818.64 Thousand CAD	-61.4%
2019 Q3	2.27 Million CAD	9.35%
2019 Q1	2.01 Million CAD	-4.8%
2019 Q2	2.08 Million CAD	3.02%
2018 Q4	2.12 Million CAD	217.46%
2018 Q3	668.06 Thousand CAD	48.63%
2018 Q1	412.2 Thousand CAD	-0.12%
2018 FY	2.12 Million CAD	413.9%
2018 Q2	449.47 Thousand CAD	9.04%
2017 Q1	58.49 Thousand CAD	0.0%
2017 FY	412.69 Thousand CAD	605.47%
2017 Q4	412.69 Thousand CAD	246.97%
2017 Q3	118.94 Thousand CAD	3.76%
2017 Q2	114.63 Thousand CAD	95.96%
2016 Q1	-210.58 Thousand CAD	-16746.64%
2016 Q4	58.49 Thousand CAD	969.61%
2016 Q2	-211.83 Thousand CAD	-0.59%
2016 Q3	-6727.00 CAD	96.82%
2016 FY	58.49 Thousand CAD	1999.75%
2015 Q4	-1250.00 CAD	0.0%
2015 Q2	- CAD	0.0%
2015 Q1	- CAD	-100.0%
2015 FY	2786.00 CAD	278500.0%
2015 Q3	- CAD	0.0%
2014 Q2	- CAD	0.0%
2014 Q3	- CAD	0.0%
2014 Q4	362.00 CAD	0.0%
2014 FY	1.00 CAD	0.0%
2014 Q1	- CAD	-100.0%
2013 Q3	- CAD	0.0%
2013 Q2	- CAD	0.0%
2013 Q1	- CAD	-100.0%
2013 Q4	345.00 CAD	0.0%
2013 FY	- CAD	0.0%
2012 FY	- CAD	0.0%
2012 Q4	345.00 CAD	0.0%
2012 Q3	- CAD	0.0%
2012 Q2	- CAD	0.0%
2012 Q1	- CAD	-100.0%
2011 Q4	725.00 CAD	0.0%
2011 Q2	- CAD	0.0%
2011 Q1	- CAD	0.0%
2011 Q3	- CAD	0.0%
2011 FY	- CAD	0.0%
2010 Q4	- CAD	0.0%
2010 Q2	- CAD	0.0%
2010 Q1	- CAD	0.0%
2010 FY	- CAD	0.0%
2010 Q3	- CAD	0.0%
2009 Q4	- CAD	0.0%
2009 Q2	- CAD	-100.0%
2009 Q3	- CAD	0.0%
2009 FY	- CAD	0.0%
2009 Q1	56.3 Thousand CAD	17.55%
2008 Q1	-389.3 Thousand CAD	-122.03%
2008 Q2	20.76 Thousand CAD	105.33%
2008 Q3	- CAD	-100.0%
2008 FY	- CAD	0.0%
2008 Q4	47.9 Thousand CAD	0.0%
2007 Q2	- CAD	100.0%
2007 Q1	-8691.00 CAD	0.0%
2007 FY	- CAD	0.0%
2007 Q4	-175.34 Thousand CAD	0.0%
2007 Q3	- CAD	0.0%
2006 Q4	- CAD	0.0%
2006 FY	- CAD	-100.0%
2006 Q1	-417.5 Thousand CAD	-11860.62%
2006 Q3	- CAD	-100.0%
2006 Q2	17.44 Thousand CAD	104.18%
2005 Q4	3550.00 CAD	-73.82%
2005 Q3	13.55 Thousand CAD	0.0%
2005 Q2	- CAD	100.0%
2005 Q1	-10.81 Thousand CAD	-427.79%
2005 FY	13.55 Thousand CAD	0.0%
2004 Q2	- CAD	100.0%
2004 Q3	- CAD	0.0%
2004 FY	- CAD	0.0%
2004 Q4	3300.00 CAD	0.0%
2004 Q1	-9109.00 CAD	-173.25%
2003 FY	- CAD	0.0%
2003 Q3	- CAD	0.0%
2003 Q1	-15.19 Thousand CAD	0.0%
2003 Q2	- CAD	100.0%
2003 Q4	12.43 Thousand CAD	0.0%
2002 FY	- CAD	0.0%
2002 Q4	- CAD	0.0%
2002 Q2	- CAD	0.0%
2002 Q1	- CAD	0.0%
2002 Q3	- CAD	0.0%
2001 Q4	- CAD	0.0%
2001 Q1	- CAD	0.0%
2001 Q2	- CAD	0.0%
2001 Q3	- CAD	0.0%
2001 FY	- CAD	0.0%
2000 Q2	- CAD	0.0%
2000 Q4	- CAD	0.0%
2000 Q1	- CAD	0.0%
2000 FY	- CAD	0.0%
2000 Q3	- CAD	0.0%
1999 FY	- CAD	0.0%
1999 Q4	- CAD	0.0%
1999 Q3	- CAD	0.0%
1998 Q3	- CAD	0.0%
1998 FY	- CAD	0.0%
1997 FY	- CAD	0.0%
1997 Q3	- CAD	0.0%
1996 FY	- CAD	0.0%

Peer Inventory Comparison of ImmunoPrecise Antibodies Ltd.

Name	Inventory	Inventory Difference
Acurx Pharmaceuticals, Inc.	- USD	-Infinity%
Adaptive Biotechnologies Corporation	14.44 Million USD	85.195%
IO Biotech, Inc.	- USD	-Infinity%
VYNE Therapeutics Inc.	- USD	-Infinity%
Organovo Holdings, Inc.	297 Thousand USD	-620.202%
TNF Pharmaceuticals, Inc.	- USD	-Infinity%
Lexaria Bioscience Corp.	1.00 USD	-213899900.0%
Tonix Pharmaceuticals Holding Corp.	14.14 Million USD	84.88%
Aadi Bioscience, Inc.	6.42 Million USD	66.719%
Savara Inc.	1.00 USD	-213899900.0%
Aerovate Therapeutics, Inc.	- USD	-Infinity%
Rocket Pharmaceuticals, Inc.	- USD	-Infinity%
Corbus Pharmaceuticals Holdings, Inc.	- USD	-Infinity%
ZyVersa Therapeutics, Inc.	- USD	-Infinity%
Soligenix, Inc.	1.00 USD	-213899900.0%
Aptose Biosciences Inc.	- USD	-Infinity%
NKGen Biotech, Inc. Common Stock	- USD	-Infinity%
Century Therapeutics, Inc.	- USD	-Infinity%
Eterna Therapeutics Inc.	- USD	-Infinity%
Precision BioSciences, Inc.	- USD	-Infinity%
Axsome Therapeutics, Inc.	15.13 Million USD	85.867%
Kura Oncology, Inc.	- USD	-Infinity%
Xenetic Biosciences, Inc.	- USD	-Infinity%
Dyadic International, Inc.	1.00 USD	-213899900.0%
TScan Therapeutics, Inc.	- USD	-Infinity%
IDEAYA Biosciences, Inc.	532.61 Million USD	99.598%
CytomX Therapeutics, Inc.	- USD	-Infinity%
Autolus Therapeutics plc	-24.54 Million USD	108.716%
Eton Pharmaceuticals, Inc.	911 Thousand USD	-134.797%
EyePoint Pharmaceuticals, Inc.	3.9 Million USD	45.238%
GRI Bio, Inc.	- USD	-Infinity%
Tenaya Therapeutics, Inc.	- USD	-Infinity%
IGM Biosciences, Inc.	- USD	-Infinity%
Heron Therapeutics, Inc.	42.11 Million USD	94.92%
SAB Biotherapeutics, Inc.	- USD	-Infinity%
Entero Therapeutics, Inc.	- USD	-Infinity%
Opthea Limited	- USD	-Infinity%
X4 Pharmaceuticals, Inc.	- USD	-Infinity%
Atara Biotherapeutics, Inc.	9.7 Million USD	77.962%
Pliant Therapeutics, Inc.	- USD	-Infinity%
Ligand Pharmaceuticals Incorporated	23.96 Million USD	91.076%
Surrozen, Inc.	1.00 USD	-213899900.0%
Lixte Biotechnology Holdings, Inc.	- USD	-Infinity%
Cingulate Inc.	-14.62 Thousand USD	14728.642%
Ovid Therapeutics Inc.	- USD	-Infinity%
Sorrento Therapeutics, Inc.	9.97 Million USD	78.559%
Acelyrin, Inc.	8.85 Million USD	75.833%
Centessa Pharmaceuticals plc	1.00 USD	-213899900.0%
Hepion Pharmaceuticals, Inc.	- USD	-Infinity%
Arcturus Therapeutics Holdings Inc.	1.00 USD	-213899900.0%
Syros Pharmaceuticals, Inc.	- USD	-Infinity%
ADMA Biologics, Inc.	172.9 Million USD	98.763%
PureTech Health plc	- USD	-Infinity%
Oncternal Therapeutics, Inc.	1.00 USD	-213899900.0%
FibroBiologics, Inc. Common Stock	- USD	-Infinity%
Barinthus Biotherapeutics plc	1.00 USD	-213899900.0%
Kymera Therapeutics, Inc.	1.00 USD	-213899900.0%
Synaptogenix, Inc.	- USD	-Infinity%
Tiziana Life Sciences Ltd	- USD	-Infinity%
ChromaDex Corporation	14.52 Million USD	85.274%
Inhibikase Therapeutics, Inc.	- USD	-Infinity%
Monopar Therapeutics Inc.	- USD	-Infinity%
Exelixis, Inc.	17.32 Million USD	87.652%
Akebia Therapeutics, Inc.	15.69 Million USD	86.368%
Better Therapeutics, Inc.	- USD	-Infinity%
Nurix Therapeutics, Inc.	- USD	-Infinity%
Apellis Pharmaceuticals, Inc.	146.36 Million USD	98.539%
Sangamo Therapeutics, Inc.	- USD	-Infinity%
Seer, Inc.	4.49 Million USD	52.371%
Aridis Pharmaceuticals, Inc.	- USD	-Infinity%
LAVA Therapeutics N.V.	- USD	-Infinity%
Gritstone bio, Inc.	- USD	-Infinity%
Jasper Therapeutics, Inc.	- USD	-Infinity%
Avid Bioservices, Inc.	30.37 Million USD	92.958%
Insmed Incorporated	83.24 Million USD	97.431%
Panbela Therapeutics, Inc.	- USD	-Infinity%
Avalo Therapeutics, Inc.	- USD	-Infinity%
Fate Therapeutics, Inc.	- USD	-Infinity%
MediWound Ltd.	2.84 Million USD	24.842%
BioXcel Therapeutics, Inc.	1.99 Million USD	-7.433%
Fortress Biotech, Inc.	10.2 Million USD	79.042%
OmniAb, Inc.	1.00 USD	-213899900.0%
Seres Therapeutics, Inc.	29.64 Million USD	92.785%
Zai Lab Limited	44.82 Million USD	95.228%
Revance Therapeutics, Inc.	45.57 Million USD	95.307%
Tarsus Pharmaceuticals, Inc.	3.1 Million USD	31.155%
Veracyte, Inc.	16.12 Million USD	86.737%
Abeona Therapeutics Inc.	- USD	-Infinity%
FibroGen, Inc.	41.56 Million USD	94.854%
Apogee Therapeutics, Inc.	- USD	-Infinity%
ContextLogic Inc.	- USD	-Infinity%
Intensity Therapeutics, Inc.	- USD	-Infinity%
Adial Pharmaceuticals, Inc.	- USD	-Infinity%
HOOKIPA Pharma Inc.	- USD	-Infinity%
Jazz Pharmaceuticals plc	597.03 Million USD	99.642%
Entrada Therapeutics, Inc.	1.00 USD	-213899900.0%
Cyclacel Pharmaceuticals, Inc.	- USD	-Infinity%
ImmuCell Corporation	7.81 Million USD	72.618%
Fortrea Holdings Inc.	35.3 Million USD	93.941%
KalVista Pharmaceuticals, Inc.	- USD	-Infinity%
Jasper Therapeutics, Inc.	- USD	-Infinity%
Foghorn Therapeutics Inc.	- USD	-Infinity%
Ultragenyx Pharmaceutical Inc.	33.96 Million USD	93.703%
Theravance Biopharma, Inc.	1.00 USD	-213899900.0%
Metagenomi, Inc. Common Stock	- USD	-Infinity%
Vaxxinity, Inc.	- USD	-Infinity%
BioCryst Pharmaceuticals, Inc.	28.68 Million USD	92.543%
Gain Therapeutics, Inc.	- USD	-Infinity%
Creative Medical Technology Holdings, Inc.	6594.00 USD	-32338.581%
Marker Therapeutics, Inc.	1.00 USD	-213899900.0%
CASI Pharmaceuticals, Inc.	15.87 Million USD	86.528%
Senti Biosciences, Inc.	- USD	-Infinity%
BioRestorative Therapies, Inc.	1.00 USD	-213899900.0%
Apollomics, Inc.	-466 Thousand USD	559.013%
89bio, Inc.	- USD	-Infinity%
Arrowhead Pharmaceuticals, Inc.	- USD	-Infinity%
TransCode Therapeutics, Inc.	- USD	-Infinity%
RAPT Therapeutics, Inc.	- USD	-Infinity%
Ardelyx, Inc.	12.44 Million USD	82.817%
Pluri Inc.	222 Thousand USD	-863.514%
Prothena Corporation plc	-5.15 Million USD	141.462%
Pulmatrix, Inc.	- USD	-Infinity%
Celularity Inc.	5.75 Million USD	62.819%
MeiraGTx Holdings plc	- USD	-Infinity%
Omeros Corporation	8.58 Million USD	75.073%
Ainos, Inc.	167.59 Thousand USD	-1176.306%
Humacyte, Inc.	- USD	-Infinity%
Mesoblast Limited	- USD	-Infinity%
Cocrystal Pharma, Inc.	- USD	-Infinity%
Cidara Therapeutics, Inc.	6.09 Million USD	64.917%
Blueprint Medicines Corporation	21.22 Million USD	89.921%
Cabaletta Bio, Inc.	- USD	-Infinity%
Summit Therapeutics Inc.	2.44 Million USD	12.372%
Alaunos Therapeutics, Inc.	- USD	-Infinity%
Scholar Rock Holding Corporation	- USD	-Infinity%
Intellia Therapeutics, Inc.	- USD	-Infinity%
Adlai Nortye Ltd. American Depositary Shares	1.00 USD	-213899900.0%
Cytokinetics, Incorporated	- USD	-Infinity%
Eloxx Pharmaceuticals, Inc.	- USD	-Infinity%
Nutriband Inc.	168.6 Thousand USD	-1168.646%
Protara Therapeutics, Inc.	- USD	-Infinity%
Roivant Sciences Ltd.	35.25 Million USD	93.932%
Evogene Ltd.	1.69 Million USD	-26.344%
Applied Therapeutics, Inc.	- USD	-Infinity%
Hoth Therapeutics, Inc.	- USD	-Infinity%
BridgeBio Pharma, Inc.	16.65 Million USD	87.155%
BioLineRx Ltd.	1.95 Million USD	-9.524%
Atai Life Sciences N.V.	1.00 USD	-213899900.0%
VistaGen Therapeutics, Inc.	- USD	-Infinity%
Aurinia Pharmaceuticals Inc.	39.7 Million USD	94.613%
MediciNova, Inc.	- USD	-Infinity%
Praxis Precision Medicines, Inc.	- USD	-Infinity%
MiMedx Group, Inc.	21.02 Million USD	89.824%
PTC Therapeutics, Inc.	30.57 Million USD	93.005%
Cullinan Oncology, Inc.	-5.4 Million USD	139.611%
Syndax Pharmaceuticals, Inc.	2 Million USD	-6.79%
Pasithea Therapeutics Corp.	-40.5 Thousand USD	5381.481%
NRx Pharmaceuticals, Inc.	-6000.00 USD	35750.0%
4D Molecular Therapeutics, Inc.	- USD	-Infinity%
Dyne Therapeutics, Inc.	- USD	-Infinity%
Kiniksa Pharmaceuticals, Ltd.	31.12 Million USD	93.127%
Ventyx Biosciences, Inc.	-800 Thousand USD	367.375%
Allakos Inc.	- USD	-Infinity%
Fulcrum Therapeutics, Inc.	- USD	-Infinity%
Corcept Therapeutics Incorporated	7.73 Million USD	72.329%
BioAtla, Inc.	- USD	-Infinity%
Allogene Therapeutics, Inc.	-1.7 Million USD	225.824%
Larimar Therapeutics, Inc.	- USD	-Infinity%
Precigen, Inc.	1.00 USD	-213899900.0%
BriaCell Therapeutics Corp.	-1.36 Million USD	256.244%
XOMA Corporation	1.00 USD	-213899900.0%
Kezar Life Sciences, Inc.	- USD	-Infinity%
Incyte Corporation	62.97 Million USD	96.603%
Cara Therapeutics, Inc.	2.82 Million USD	24.176%
Aligos Therapeutics, Inc.	- USD	-Infinity%
Reviva Pharmaceuticals Holdings, Inc.	- USD	-Infinity%
CRISPR Therapeutics AG	- USD	-Infinity%
Akero Therapeutics, Inc.	- USD	-Infinity%
Eliem Therapeutics, Inc.	- USD	-Infinity%
EyeGate Pharmaceuticals, Inc.	- USD	-Infinity%
UroGen Pharma Ltd.	5.67 Million USD	62.295%
Sutro Biopharma, Inc.	1.00 USD	-213899900.0%
ZIVO Bioscience, Inc.	- USD	-Infinity%
Lisata Therapeutics, Inc.	- USD	-Infinity%
Stoke Therapeutics, Inc.	- USD	-Infinity%
Chimerix, Inc.	- USD	-Infinity%
Outlook Therapeutics, Inc.	- USD	-Infinity%
60 Degrees Pharmaceuticals, Inc.	466.16 Thousand USD	-358.846%
Enanta Pharmaceuticals, Inc.	- USD	-Infinity%
Aprea Therapeutics, Inc.	- USD	-Infinity%
Portage Biotech Inc.	- USD	-Infinity%
OncoCyte Corporation	- USD	-Infinity%
Qualigen Therapeutics, Inc.	- USD	-Infinity%
Cadrenal Therapeutics, Inc. Common Stock	- USD	-Infinity%
Processa Pharmaceuticals, Inc.	- USD	-Infinity%
Purple Biotech Ltd.	- USD	-Infinity%
NextCure, Inc.	- USD	-Infinity%
ProMIS Neurosciences, Inc.	- USD	-Infinity%
Dermata Therapeutics, Inc.	- USD	-Infinity%
Generation Bio Co.	3.81 Million USD	43.947%
Neumora Therapeutics, Inc. Common Stock	- USD	-Infinity%
Xeris Biopharma Holdings, Inc.	38.83 Million USD	94.493%
TRACON Pharmaceuticals, Inc.	- USD	-Infinity%
NLS Pharmaceutics AG	- USD	-Infinity%
Mineralys Therapeutics, Inc.	- USD	-Infinity%
Novavax, Inc.	41.69 Million USD	94.87%
Virios Therapeutics, Inc.	- USD	-Infinity%
Curis, Inc.	- USD	-Infinity%
Daré Bioscience, Inc.	- USD	-Infinity%
Titan Pharmaceuticals, Inc.	- USD	-Infinity%
Virpax Pharmaceuticals, Inc.	- USD	-Infinity%
Bicycle Therapeutics plc	- USD	-Infinity%
BeiGene, Ltd.	416.12 Million USD	99.486%
Kiromic BioPharma, Inc.	- USD	-Infinity%
Alector, Inc.	- USD	-Infinity%
Protagonist Therapeutics, Inc.	-10.33 Million USD	120.703%
Erasca, Inc.	- USD	-Infinity%
Checkpoint Therapeutics, Inc.	- USD	-Infinity%
Aura Biosciences, Inc.	- USD	-Infinity%
Viracta Therapeutics, Inc.	- USD	-Infinity%
Chemomab Therapeutics Ltd.	-1.03 Million USD	306.267%
Protagenic Therapeutics, Inc.	- USD	-Infinity%
Pieris Pharmaceuticals, Inc.	4.08 Million USD	47.663%
BioMarin Pharmaceutical Inc.	1.1 Billion USD	99.807%
Histogen Inc.	400 Thousand USD	-434.75%
Fortress Biotech, Inc.	10.2 Million USD	79.042%
Avidity Biosciences, Inc.	- USD	-Infinity%
Lyell Immunopharma, Inc.	- USD	-Infinity%
Galecto, Inc.	1.00 USD	-213899900.0%
InMed Pharmaceuticals Inc.	1.24 Million USD	-71.901%
Phathom Pharmaceuticals, Inc.	1.2 Million USD	-77.07%
Molecular Templates, Inc.	- USD	-Infinity%
PDS Biotechnology Corporation	- USD	-Infinity%
Amylyx Pharmaceuticals, Inc.	38.32 Million USD	94.418%
Amarin Corporation plc	258.61 Million USD	99.173%
TG Therapeutics, Inc.	39.82 Million USD	94.629%
Aptevo Therapeutics Inc.	- USD	-Infinity%
Celldex Therapeutics, Inc.	1.00 USD	-213899900.0%
Cogent Biosciences, Inc.	- USD	-Infinity%
Onconetix, Inc.	364.05 Thousand USD	-487.553%
MacroGenics, Inc.	1.22 Million USD	-75.184%
Y-mAbs Therapeutics, Inc.	5.06 Million USD	57.769%
Ocuphire Pharma, Inc.	- USD	-Infinity%
Adagene Inc.	- USD	-Infinity%
Inhibrx Biosciences, Inc.	- USD	-Infinity%
Cartesian Therapeutics, Inc.	- USD	-Infinity%
Voyager Therapeutics, Inc.	1.00 USD	-213899900.0%
SciSparc Ltd.	742 Thousand USD	-188.275%
Revelation Biosciences, Inc.	- USD	-Infinity%
Minerva Neurosciences, Inc.	- USD	-Infinity%
Astria Therapeutics, Inc.	- USD	-Infinity%
Black Diamond Therapeutics, Inc.	- USD	-Infinity%
Arcutis Biotherapeutics, Inc.	13.13 Million USD	83.714%
Relay Therapeutics, Inc.	- USD	-Infinity%
Alnylam Pharmaceuticals, Inc.	89.14 Million USD	97.601%
Psyence Biomedical Ltd.	- USD	-Infinity%
Artelo Biosciences, Inc.	- USD	-Infinity%
2seventy bio, Inc.	-13.41 Million USD	115.95%
Clene Inc.	37 Thousand USD	-5681.081%
Boundless Bio, Inc. Common Stock	- USD	-Infinity%
GeoVax Labs, Inc.	- USD	-Infinity%
Sonnet BioTherapeutics Holdings, Inc.	- USD	-Infinity%
Arbutus Biopharma Corporation	-1.77 Million USD	220.439%
Scopus BioPharma Inc.	- USD	-Infinity%
Absci Corporation	- USD	-Infinity%
XBiotech Inc.	- USD	-Infinity%
ALX Oncology Holdings Inc.	- USD	-Infinity%
Lyra Therapeutics, Inc.	- USD	-Infinity%
Entera Bio Ltd.	- USD	-Infinity%
Trevena, Inc.	- USD	-Infinity%
Adaptimmune Therapeutics plc	1.32 Million USD	-60.948%
Caribou Biosciences, Inc.	- USD	-Infinity%
INmune Bio, Inc.	- USD	-Infinity%
Citius Pharmaceuticals, Inc.	- USD	-Infinity%
Tyra Biosciences, Inc.	- USD	-Infinity%
Galmed Pharmaceuticals Ltd.	- USD	-Infinity%
Unity Biotechnology, Inc.	- USD	-Infinity%
Tenax Therapeutics, Inc.	- USD	-Infinity%
Jaguar Health, Inc.	9.18 Million USD	76.722%
Clearside Biomedical, Inc.	1.00 USD	-213899900.0%
NexImmune, Inc.	- USD	-Infinity%
Connect Biopharma Holdings Limited	-13.95 Million USD	115.333%
Clearmind Medicine Inc.	-11.39 Thousand USD	18872.874%
Coeptis Therapeutics Holdings, Inc.	- USD	-Infinity%
Kronos Bio, Inc.	- USD	-Infinity%
Innoviva, Inc.	40.73 Million USD	94.749%
Coherus BioSciences, Inc.	62.6 Million USD	96.583%
Regeneron Pharmaceuticals, Inc.	2.58 Billion USD	99.917%
Bolt Biotherapeutics, Inc.	- USD	-Infinity%
Verastem, Inc.	- USD	-Infinity%
ProKidney Corp.	- USD	-Infinity%
CERo Therapeutics Holdings, Inc.	- USD	-Infinity%
Imunon, Inc.	- USD	-Infinity%
Viking Therapeutics, Inc.	- USD	-Infinity%
Statera Biopharma, Inc.	1.8 Million USD	-18.351%
ImmunityBio, Inc.	- USD	-Infinity%
Korro Bio, Inc.	- USD	-Infinity%
Travere Therapeutics, Inc.	9.41 Million USD	77.269%
Kineta, Inc.	- USD	-Infinity%
Catalyst Pharmaceuticals, Inc.	15.64 Million USD	86.327%
Capricor Therapeutics, Inc.	1.00 USD	-213899900.0%
GT Biopharma, Inc.	- USD	-Infinity%
Keros Therapeutics, Inc.	14.05 Million USD	84.78%
Celularity Inc.	5.75 Million USD	62.819%
Crinetics Pharmaceuticals, Inc.	- USD	-Infinity%
CalciMedica, Inc.	- USD	-Infinity%
Cibus, Inc.	- USD	-Infinity%
C4 Therapeutics, Inc.	- USD	-Infinity%
Marinus Pharmaceuticals, Inc.	2.41 Million USD	11.355%
Eledon Pharmaceuticals, Inc.	- USD	-Infinity%
Kodiak Sciences Inc.	- USD	-Infinity%
Sana Biotechnology, Inc.	- USD	-Infinity%
Annexon, Inc.	- USD	-Infinity%
Adverum Biotechnologies, Inc.	- USD	-Infinity%
Assembly Biosciences, Inc.	1.00 USD	-213899900.0%
Elicio Therapeutics, Inc.	- USD	-Infinity%
Moderna, Inc.	202 Million USD	98.941%
Vigil Neuroscience, Inc.	- USD	-Infinity%
Ionis Pharmaceuticals, Inc.	28.42 Million USD	92.475%
Vor Biopharma Inc.	- USD	-Infinity%
Eyenovia, Inc.	109.79 Thousand USD	-1848.123%
DiaMedica Therapeutics Inc.	- USD	-Infinity%
Puma Biotechnology, Inc.	7.08 Million USD	69.788%
Monte Rosa Therapeutics, Inc.	- USD	-Infinity%
Wave Life Sciences Ltd.	1.00 USD	-213899900.0%
Conduit Pharmaceuticals Inc.	- USD	-Infinity%
ACADIA Pharmaceuticals Inc.	35.81 Million USD	94.028%
Immunocore Holdings plc	4.5 Million USD	52.477%
Tango Therapeutics, Inc.	- USD	-Infinity%
Galectin Therapeutics Inc.	- USD	-Infinity%
Alkermes plc	186.4 Million USD	98.853%
Arcellx, Inc.	- USD	-Infinity%
Renovaro Biosciences Inc.	-439.31 Thousand USD	586.891%
Zentalis Pharmaceuticals, Inc.	- USD	-Infinity%
Sagimet Biosciences Inc.	- USD	-Infinity%
Regulus Therapeutics Inc.	3010.00 USD	-70963.123%
Cardio Diagnostics Holdings, Inc.	- USD	-Infinity%
Moolec Science SA	465.74 Thousand USD	-359.261%
Biomea Fusion, Inc.	- USD	-Infinity%
RenovoRx, Inc.	- USD	-Infinity%
Geron Corporation	- USD	-Infinity%
Mereo BioPharma Group plc	1.24 Million USD	-71.532%
Verrica Pharmaceuticals Inc.	1.02 Million USD	-109.295%
Royalty Pharma plc	- USD	-Infinity%
Atea Pharmaceuticals, Inc.	- USD	-Infinity%
Greenwich LifeSciences, Inc.	- USD	-Infinity%
Calithera Biosciences, Inc.	- USD	-Infinity%
TFF Pharmaceuticals, Inc.	- USD	-Infinity%
Mersana Therapeutics, Inc.	- USD	-Infinity%
Humacyte, Inc.	- USD	-Infinity%
Structure Therapeutics Inc.	- USD	-Infinity%
NLS Pharmaceutics AG	- USD	-Infinity%
Genelux Corporation	- USD	-Infinity%
ESSA Pharma Inc.	- USD	-Infinity%
aTyr Pharma, Inc.	- USD	-Infinity%
Notable Labs, Ltd.	2.88 Million USD	25.909%
Alzamend Neuro, Inc.	- USD	-Infinity%
Mustang Bio, Inc.	- USD	-Infinity%
Immunovant, Inc.	- USD	-Infinity%
Tevogen Bio Holdings Inc.	- USD	-Infinity%
Vericel Corporation	13.08 Million USD	83.656%
Halozyme Therapeutics, Inc.	127.6 Million USD	98.324%
Akari Therapeutics, Plc	- USD	-Infinity%
Acasti Pharma Inc.	- USD	-Infinity%
MiNK Therapeutics, Inc.	- USD	-Infinity%
Vaxcyte, Inc.	-6.15 Million USD	134.73%
Orgenesis Inc.	34 Thousand USD	-6191.176%
Spruce Biosciences, Inc.	- USD	-Infinity%
NeuroBo Pharmaceuticals, Inc.	- USD	-Infinity%
GH Research PLC	-178 Thousand USD	1301.685%
Tempest Therapeutics, Inc.	- USD	-Infinity%
PepGen Inc.	- USD	-Infinity%
Moleculin Biotech, Inc.	- USD	-Infinity%
Relmada Therapeutics, Inc.	- USD	-Infinity%
BriaCell Therapeutics Corp.	-1.36 Million USD	256.178%
Lixte Biotechnology Holdings, Inc.	- USD	-Infinity%
Silo Pharma, Inc.	- USD	-Infinity%
Telomir Pharmaceuticals, Inc. Common Stock	303.28 Thousand USD	-605.287%
Belite Bio, Inc	- USD	-Infinity%
Pharming Group N.V.	56.76 Million USD	96.232%
XOMA Corporation	1.00 USD	-213899900.0%
Reneo Pharmaceuticals, Inc.	- USD	-Infinity%
Reviva Pharmaceuticals Holdings, Inc.	- USD	-Infinity%
Bionomics Limited	-458.3 Million USD	100.467%
Xencor, Inc.	-11.29 Million USD	118.946%
Replimune Group, Inc.	- USD	-Infinity%
Pyxis Oncology, Inc.	- USD	-Infinity%
Cassava Sciences, Inc.	- USD	-Infinity%
Vanda Pharmaceuticals Inc.	1.35 Million USD	-57.627%
Estrella Immunopharma, Inc.	-288.76 Thousand USD	840.751%
Turnstone Biologics Corp.	4.77 Million USD	55.167%
Windtree Therapeutics, Inc.	- USD	-Infinity%
GeoVax Labs, Inc.	- USD	-Infinity%
MEI Pharma, Inc.	- USD	-Infinity%
Olema Pharmaceuticals, Inc.	- USD	-Infinity%
Cardio Diagnostics Holdings, Inc.	- USD	-Infinity%
Bio-Path Holdings, Inc.	632.00 USD	-338349.367%
Enlivex Therapeutics Ltd.	-229 Thousand USD	1034.061%
CollPlant Biotechnologies Ltd.	714 Thousand USD	-199.58%
scPharmaceuticals Inc.	8.84 Million USD	75.803%
HilleVax, Inc.	- USD	-Infinity%
Vera Therapeutics, Inc.	- USD	-Infinity%
Tharimmune, Inc.	- USD	-Infinity%
Genprex, Inc.	- USD	-Infinity%
SeaStar Medical Holding Corporation	- USD	-Infinity%
Immunic, Inc.	- USD	-Infinity%
Atossa Therapeutics, Inc.	1.48 Million USD	-43.847%
Aptorum Group Limited	- USD	-Infinity%
Soleno Therapeutics, Inc.	- USD	-Infinity%
SeaStar Medical Holding Corporation	- USD	-Infinity%
OKYO Pharma Limited	- USD	-Infinity%
Carmell Therapeutics Corporation	- USD	-Infinity%
Achieve Life Sciences, Inc.	- USD	-Infinity%
Ocean Biomedical, Inc.	- USD	-Infinity%
Amicus Therapeutics, Inc.	59.69 Million USD	96.417%
Salarius Pharmaceuticals, Inc.	- USD	-Infinity%
bluebird bio, Inc.	22.91 Million USD	90.667%
DBV Technologies S.A.	- USD	-Infinity%
Compugen Ltd.	- USD	-Infinity%
Protagenic Therapeutics, Inc.	- USD	-Infinity%
Peak Bio, Inc.	1.91 Million USD	-11.572%
Vincerx Pharma, Inc.	- USD	-Infinity%
Fresh Tracks Therapeutics, Inc.	545 Thousand USD	-292.477%
Sensei Biotherapeutics, Inc.	- USD	-Infinity%
Orchestra BioMed Holdings, Inc.	146 Thousand USD	-1365.068%
Zevra Therapeutics, Inc.	9.84 Million USD	78.264%
Acrivon Therapeutics, Inc. Common Stock	- USD	-Infinity%
Benitec Biopharma Inc.	63 Thousand USD	-3295.238%
Spyre Therapeutics, Inc.	- USD	-Infinity%
Adicet Bio, Inc.	- USD	-Infinity%
Prime Medicine, Inc.	- USD	-Infinity%
Aditxt, Inc.	745.5 Thousand USD	-186.921%
Madrigal Pharmaceuticals, Inc.	- USD	-Infinity%
Estrella Immunopharma, Inc.	-288.76 Thousand USD	840.751%
Quantum-Si incorporated	3.94 Million USD	45.779%
GlycoMimetics, Inc.	- USD	-Infinity%
PolyPid Ltd.	- USD	-Infinity%
Aileron Therapeutics, Inc.	- USD	-Infinity%
Invivyd, Inc.	- USD	-Infinity%
Quoin Pharmaceuticals, Ltd.	- USD	-Infinity%
Rigel Pharmaceuticals, Inc.	5.52 Million USD	61.264%
CorMedix Inc.	2.1 Million USD	-1.55%
Instil Bio, Inc.	- USD	-Infinity%
Recursion Pharmaceuticals, Inc.	-3.09 Million USD	169.134%
Contineum Therapeutics, Inc. Class A Common Stock	- USD	-Infinity%
Finch Therapeutics Group, Inc.	- USD	-Infinity%
Spero Therapeutics, Inc.	1.00 USD	-213899900.0%
Alpha Tau Medical Ltd.	- USD	-Infinity%
AbCellera Biologics Inc.	1.1 Million USD	-93.225%
Ocular Therapeutix, Inc.	2.3 Million USD	7.202%
Surrozen, Inc.	1.00 USD	-213899900.0%
Janux Therapeutics, Inc.	-2.2 Million USD	197.227%
Verona Pharma plc	1.00 USD	-213899900.0%
Terns Pharmaceuticals, Inc.	- USD	-Infinity%
Vir Biotechnology, Inc.	- USD	-Infinity%
Evaxion Biotech A/S	- USD	-Infinity%
Verve Therapeutics, Inc.	1.00 USD	-213899900.0%
Shattuck Labs, Inc.	- USD	-Infinity%
AlloVir, Inc.	- USD	-Infinity%
BioVie Inc.	- USD	-Infinity%
Codexis, Inc.	2.68 Million USD	20.335%
SELLAS Life Sciences Group, Inc.	- USD	-Infinity%
Lexaria Bioscience Corp.	1.00 USD	-213899900.0%
Agenus Inc.	1.00 USD	-213899900.0%
Virax Biolabs Group Limited	60.38 Thousand USD	-3442.388%
Lantern Pharma Inc.	- USD	-Infinity%
Viridian Therapeutics, Inc.	- USD	-Infinity%
eFFECTOR Therapeutics, Inc.	- USD	-Infinity%
Immix Biopharma, Inc.	- USD	-Infinity%
Celcuity Inc.	- USD	-Infinity%
Cardiff Oncology, Inc.	- USD	-Infinity%
Acumen Pharmaceuticals, Inc.	98 Thousand USD	-2082.653%
IN8bio, Inc.	- USD	-Infinity%
Avenue Therapeutics, Inc.	- USD	-Infinity%
Trevi Therapeutics, Inc.	- USD	-Infinity%
Lexicon Pharmaceuticals, Inc.	381 Thousand USD	-461.417%
Liquidia Corporation	1.00 USD	-213899900.0%
Quantum-Si incorporated	3.94 Million USD	45.779%
Pasithea Therapeutics Corp.	-40.5 Thousand USD	5381.481%
Xenon Pharmaceuticals Inc.	1.00 USD	-213899900.0%
Sol-Gel Technologies Ltd.	- USD	-Infinity%
United Therapeutics Corporation	111.8 Million USD	98.087%
Solid Biosciences Inc.	- USD	-Infinity%
Immuneering Corporation	- USD	-Infinity%
Alpha Tau Medical Ltd.	- USD	-Infinity%
uniQure N.V.	12.02 Million USD	82.211%
Xilio Therapeutics, Inc.	- USD	-Infinity%
Enveric Biosciences, Inc.	- USD	-Infinity%
Poseida Therapeutics, Inc.	1.00 USD	-213899900.0%
Longboard Pharmaceuticals, Inc.	- USD	-Infinity%
PMV Pharmaceuticals, Inc.	- USD	-Infinity%
Elevai Labs, Inc. Common Stock	598.78 Thousand USD	-257.222%
Cue Biopharma, Inc.	1.00 USD	-213899900.0%
Nuvectis Pharma, Inc.	- USD	-Infinity%
ARS Pharmaceuticals, Inc.	- USD	-Infinity%
Zura Bio Limited	- USD	-Infinity%
Forte Biosciences, Inc.	- USD	-Infinity%
Elevation Oncology, Inc.	- USD	-Infinity%
Conduit Pharmaceuticals Inc.	- USD	-Infinity%
Immunome, Inc.	- USD	-Infinity%
Compass Therapeutics, Inc.	- USD	-Infinity%
enGene Holdings Inc. Warrants	76 Thousand USD	-2714.474%
Inovio Pharmaceuticals, Inc.	- USD	-Infinity%
LENZ Therapeutics, Inc.	- USD	-Infinity%
Altimmune, Inc.	- USD	-Infinity%
Milestone Pharmaceuticals Inc.	- USD	-Infinity%
Rallybio Corporation	- USD	-Infinity%
Plus Therapeutics, Inc.	- USD	-Infinity%
Dianthus Therapeutics, Inc.	- USD	-Infinity%
Moolec Science SA	465.74 Thousand USD	-359.261%
Anebulo Pharmaceuticals, Inc.	- USD	-Infinity%
XTL Biopharmaceuticals Ltd.	- USD	-Infinity%
Tourmaline Bio, Inc.	- USD	-Infinity%
NeurAxis, Inc.	21.22 Thousand USD	-9980.113%
Maravai LifeSciences Holdings, Inc.	51.39 Million USD	95.838%
Lumos Pharma, Inc.	- USD	-Infinity%
enGene Holdings Inc. Common Stock	76 Thousand USD	-2714.474%
180 Life Sciences Corp.	- USD	-Infinity%
NKGen Biotech, Inc. Warrants	- USD	-Infinity%
Opiant Pharmaceuticals, Inc.	-2.95 Billion USD	100.072%
CERo Therapeutics Holdings, Inc.	- USD	-Infinity%
Nutriband Inc.	168.6 Thousand USD	-1168.646%
CG Oncology, Inc. Common stock	- USD	-Infinity%
argenx SE	310.55 Million USD	99.311%
Neurogene Inc.	1.49 Million USD	-42.981%
Mirum Pharmaceuticals, Inc.	22.31 Million USD	90.413%
Kintara Therapeutics, Inc.	- USD	-Infinity%
CervoMed Inc.	- USD	-Infinity%
CARGO Therapeutics, Inc. Common Stock	- USD	-Infinity%
Sesen Bio, Inc.	21 Million USD	89.814%
AnaptysBio, Inc.	1.00 USD	-213899900.0%
Design Therapeutics, Inc.	- USD	-Infinity%
Leap Therapeutics, Inc.	- USD	-Infinity%
Seelos Therapeutics, Inc.	1.00 USD	-213899900.0%
Achilles Therapeutics plc	1.00 USD	-213899900.0%
NeuroSense Therapeutics Ltd.	- USD	-Infinity%
ORIC Pharmaceuticals, Inc.	- USD	-Infinity%
Fractyl Health, Inc. Common Stock	73 Thousand USD	-2830.137%
Rani Therapeutics Holdings, Inc.	- USD	-Infinity%
MoonLake Immunotherapeutics	- USD	-Infinity%
Palisade Bio, Inc.	- USD	-Infinity%
Beam Therapeutics Inc.	- USD	-Infinity%
AEON Biopharma, Inc.	- USD	-Infinity%
Enliven Therapeutics, Inc.	- USD	-Infinity%
Kiora Pharmaceuticals, Inc.	1.00 USD	-213899900.0%
Iovance Biotherapeutics, Inc.	10.37 Million USD	79.377%
Taysha Gene Therapies, Inc.	- USD	-Infinity%
Athira Pharma, Inc.	- USD	-Infinity%
Vaccinex, Inc.	- USD	-Infinity%
HCW Biologics Inc.	- USD	-Infinity%
XOMA Corporation	1.00 USD	-213899900.0%
Nektar Therapeutics	16.1 Million USD	86.715%
Arvinas, Inc.	- USD	-Infinity%
Tevogen Bio Holdings Inc.	- USD	-Infinity%
Merus N.V.	1.00 USD	-213899900.0%
Omega Therapeutics, Inc.	- USD	-Infinity%
Quince Therapeutics, Inc.	- USD	-Infinity%
Rezolute, Inc.	- USD	-Infinity%
Clene Inc.	37 Thousand USD	-5681.081%
Indaptus Therapeutics, Inc.	- USD	-Infinity%
BeyondSpring Inc.	- USD	-Infinity%
Synlogic, Inc.	- USD	-Infinity%
Allarity Therapeutics, Inc.	- USD	-Infinity%
Phio Pharmaceuticals Corp.	- USD	-Infinity%
Peak Bio, Inc.	1.91 Million USD	-11.572%
Werewolf Therapeutics, Inc.	- USD	-Infinity%
Krystal Biotech, Inc.	6.98 Million USD	69.377%
Karyopharm Therapeutics Inc.	3.04 Million USD	29.708%
SpringWorks Therapeutics, Inc.	3.1 Million USD	31.067%
Lipella Pharmaceuticals Inc.	- USD	-Infinity%
MannKind Corporation	28.54 Million USD	92.507%
Ikena Oncology, Inc.	- USD	-Infinity%
Cyclerion Therapeutics, Inc.	- USD	-Infinity%
Gyre Therapeutics, Inc.	4.28 Million USD	50.035%
Gossamer Bio, Inc.	- USD	-Infinity%
CohBar, Inc.	- USD	-Infinity%
Cognition Therapeutics, Inc.	- USD	-Infinity%
NRx Pharmaceuticals, Inc.	-6000.00 USD	35750.0%
Legend Biotech Corporation	19.43 Million USD	88.993%
Mural Oncology plc	150 Thousand USD	-1326.0%
Biora Therapeutics, Inc.	- USD	-Infinity%
PaxMedica, Inc. Common Stock	- USD	-Infinity%
Disc Medicine, Inc.	- USD	-Infinity%
Champions Oncology, Inc.	1.00 USD	-213899900.0%
REGENXBIO Inc.	- USD	-Infinity%
Ensysce Biosciences, Inc.	-97.56 Thousand USD	2292.474%
Anavex Life Sciences Corp.	- USD	-Infinity%
Cellectar Biosciences, Inc.	- USD	-Infinity%
Edgewise Therapeutics, Inc.	- USD	-Infinity%
Vaxart, Inc.	1.00 USD	-213899900.0%
PharmaCyte Biotech, Inc.	- USD	-Infinity%
Aldeyra Therapeutics, Inc.	- USD	-Infinity%
Cellectis S.A.	- USD	-Infinity%
Longeveron Inc.	- USD	-Infinity%
Repare Therapeutics Inc.	2.00 USD	-106949900.0%
Sarepta Therapeutics, Inc.	322.85 Million USD	99.337%
Inozyme Pharma, Inc.	- USD	-Infinity%
Revolution Medicines, Inc.	1.00 USD	-213899900.0%
Nymox Pharmaceutical Corporation	28 Thousand USD	-7539.286%
Third Harmonic Bio, Inc.	- USD	-Infinity%
ArriVent BioPharma, Inc. Common Stock	- USD	-Infinity%
AN2 Therapeutics, Inc.	- USD	-Infinity%
Anixa Biosciences, Inc.	- USD	-Infinity%
Vertex Pharmaceuticals Incorporated	738.8 Million USD	99.71%
Denali Therapeutics Inc.	1.00 USD	-213899900.0%
Revelation Biosciences, Inc.	- USD	-Infinity%
Veru Inc.	6.69 Million USD	68.061%
Corvus Pharmaceuticals, Inc.	- USD	-Infinity%
Cingulate Inc.	-14.62 Thousand USD	14728.642%
Passage Bio, Inc.	- USD	-Infinity%
Context Therapeutics Inc.	- USD	-Infinity%
Exicure, Inc.	- USD	-Infinity%
Day One Biopharmaceuticals, Inc.	- USD	-Infinity%
Oramed Pharmaceuticals Inc.	- USD	-Infinity%
Revolution Medicines, Inc. Warrant	1.00 USD	-213899900.0%
Scinai Immunotherapeutics Ltd.	-1.87 Million USD	214.11%
Rhythm Pharmaceuticals, Inc.	8.62 Million USD	75.197%
Nuvalent, Inc.	- USD	-Infinity%
ABVC BioPharma, Inc.	- USD	-Infinity%
Carisma Therapeutics, Inc.	- USD	-Infinity%
Unicycive Therapeutics, Inc.	- USD	-Infinity%
OmniAb, Inc.	1.00 USD	-213899900.0%
Anew Medical, Inc.	- USD	-Infinity%
Fennec Pharmaceuticals Inc.	2.14 Million USD	0.278%
Lipocine Inc.	- USD	-Infinity%
Lexeo Therapeutics, Inc. Common Stock	- USD	-Infinity%
Nautilus Biotechnology, Inc.	- USD	-Infinity%
SAB Biotherapeutics, Inc.	- USD	-Infinity%
G1 Therapeutics, Inc.	12.44 Million USD	82.808%
Bellerophon Therapeutics, Inc.	- USD	-Infinity%
Sage Therapeutics, Inc.	1.33 Million USD	-60.586%
Ocugen, Inc.	- USD	-Infinity%
Mind Medicine (MindMed) Inc.	- USD	-Infinity%
Q32 Bio Inc.	- USD	-Infinity%
Brainstorm Cell Therapeutics Inc.	-51 Thousand USD	4294.118%
Alumis Inc. Common Stock	- USD	-Infinity%
Equillium, Inc.	- USD	-Infinity%
Kyverna Therapeutics, Inc.	- USD	-Infinity%
Coya Therapeutics, Inc.	- USD	-Infinity%
CNS Pharmaceuticals, Inc.	- USD	-Infinity%
Galera Therapeutics, Inc.	- USD	-Infinity%
Evelo Biosciences, Inc.	- USD	-Infinity%
Comera Life Sciences Holdings, Inc.	2.5 Million USD	14.757%
Dominari Holdings Inc.	1.00 USD	-213899900.0%
Edesa Biotech, Inc.	- USD	-Infinity%
vTv Therapeutics Inc.	- USD	-Infinity%
Bio-Techne Corporation	179.73 Million USD	98.81%
Agios Pharmaceuticals, Inc.	19.07 Million USD	88.787%
Harmony Biosciences Holdings, Inc.	5.36 Million USD	60.116%
Prelude Therapeutics Incorporated	- USD	-Infinity%
Candel Therapeutics, Inc.	- USD	-Infinity%
iTeos Therapeutics, Inc.	- USD	-Infinity%
Nkarta, Inc.	- USD	-Infinity%
BioCardia, Inc.	- USD	-Infinity%
Iterum Therapeutics plc	- USD	-Infinity%

Global Stocks Search

ImmunoPrecise Antibodies Ltd. (IPA)

Inventory Summary of ImmunoPrecise Antibodies Ltd.

Annual Inventory Chart of ImmunoPrecise Antibodies Ltd. (2023 - 1996)

Historical Annual Inventory of ImmunoPrecise Antibodies Ltd. (2023 - 1996)

Peer Inventory Comparison of ImmunoPrecise Antibodies Ltd.